サマリー

市場分析と洞察。処方箋付き鎮痛剤の世界市場
処方箋付き鎮痛剤の世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX％のCAGRで推移し、2027年にはXX百万米ドルに達すると予測しています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の処方箋付き鎮痛剤市場で得られる主要な機会を明らかにし、プレイヤーが市場で確固たる地位を築くのに役立つよう、見事な試みを行っています。本レポートの購入者は、検証済みで信頼性の高い市場予測にアクセスすることができ、その中には収入面での処方鎮痛剤の世界市場全体の規模も含まれています。
全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の処方箋付き鎮痛剤市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の処方箋付き鎮痛剤市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の処方箋付き鎮痛剤の範囲と市場規模
処方箋付き鎮痛剤市場は、企業別、地域別（国別）、タイプ別、用途別に分類されています。世界の処方箋付き鎮痛剤市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
ジェネリックオピオイド
ブランドオピオイド
NSAIDs
その他

用途別セグメント
病院
診療所
ドラッグストア

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ファイザー
GSK
グルーネンタール
バイエル
サノフィ
イーライリリー
アストラゼネカ
エンド
メルク
デポメッド
雲南白羊
テバ
J&J
アラガン
パデュー

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Pain Relievers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prescription Pain Relievers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prescription Pain Relievers Market Perspective (2016-2027)
2.2 Prescription Pain Relievers Growth Trends by Regions
2.2.1 Prescription Pain Relievers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prescription Pain Relievers Historic Market Share by Regions (2016-2021)
2.2.3 Prescription Pain Relievers Forecasted Market Size by Regions (2022-2027)
2.3 Prescription Pain Relievers Industry Dynamic
2.3.1 Prescription Pain Relievers Market Trends
2.3.2 Prescription Pain Relievers Market Drivers
2.3.3 Prescription Pain Relievers Market Challenges
2.3.4 Prescription Pain Relievers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prescription Pain Relievers Players by Revenue
3.1.1 Global Top Prescription Pain Relievers Players by Revenue (2016-2021)
3.1.2 Global Prescription Pain Relievers Revenue Market Share by Players (2016-2021)
3.2 Global Prescription Pain Relievers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prescription Pain Relievers Revenue
3.4 Global Prescription Pain Relievers Market Concentration Ratio
3.4.1 Global Prescription Pain Relievers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Pain Relievers Revenue in 2020
3.5 Prescription Pain Relievers Key Players Head office and Area Served
3.6 Key Players Prescription Pain Relievers Product Solution and Service
3.7 Date of Enter into Prescription Pain Relievers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prescription Pain Relievers Breakdown Data by Type
4.1 Global Prescription Pain Relievers Historic Market Size by Type (2016-2021)
4.2 Global Prescription Pain Relievers Forecasted Market Size by Type (2022-2027)

5 Prescription Pain Relievers Breakdown Data by Application
5.1 Global Prescription Pain Relievers Historic Market Size by Application (2016-2021)
5.2 Global Prescription Pain Relievers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prescription Pain Relievers Market Size (2016-2027)
6.2 North America Prescription Pain Relievers Market Size by Type
6.2.1 North America Prescription Pain Relievers Market Size by Type (2016-2021)
6.2.2 North America Prescription Pain Relievers Market Size by Type (2022-2027)
6.2.3 North America Prescription Pain Relievers Market Size by Type (2016-2027)
6.3 North America Prescription Pain Relievers Market Size by Application
6.3.1 North America Prescription Pain Relievers Market Size by Application (2016-2021)
6.3.2 North America Prescription Pain Relievers Market Size by Application (2022-2027)
6.3.3 North America Prescription Pain Relievers Market Size by Application (2016-2027)
6.4 North America Prescription Pain Relievers Market Size by Country
6.4.1 North America Prescription Pain Relievers Market Size by Country (2016-2021)
6.4.2 North America Prescription Pain Relievers Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prescription Pain Relievers Market Size (2016-2027)
7.2 Europe Prescription Pain Relievers Market Size by Type
7.2.1 Europe Prescription Pain Relievers Market Size by Type (2016-2021)
7.2.2 Europe Prescription Pain Relievers Market Size by Type (2022-2027)
7.2.3 Europe Prescription Pain Relievers Market Size by Type (2016-2027)
7.3 Europe Prescription Pain Relievers Market Size by Application
7.3.1 Europe Prescription Pain Relievers Market Size by Application (2016-2021)
7.3.2 Europe Prescription Pain Relievers Market Size by Application (2022-2027)
7.3.3 Europe Prescription Pain Relievers Market Size by Application (2016-2027)
7.4 Europe Prescription Pain Relievers Market Size by Country
7.4.1 Europe Prescription Pain Relievers Market Size by Country (2016-2021)
7.4.2 Europe Prescription Pain Relievers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prescription Pain Relievers Market Size (2016-2027)
8.2 Asia-Pacific Prescription Pain Relievers Market Size by Type
8.2.1 Asia-Pacific Prescription Pain Relievers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prescription Pain Relievers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prescription Pain Relievers Market Size by Type (2016-2027)
8.3 Asia-Pacific Prescription Pain Relievers Market Size by Application
8.3.1 Asia-Pacific Prescription Pain Relievers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prescription Pain Relievers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prescription Pain Relievers Market Size by Application (2016-2027)
8.4 Asia-Pacific Prescription Pain Relievers Market Size by Region
8.4.1 Asia-Pacific Prescription Pain Relievers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prescription Pain Relievers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prescription Pain Relievers Market Size (2016-2027)
9.2 Latin America Prescription Pain Relievers Market Size by Type
9.2.1 Latin America Prescription Pain Relievers Market Size by Type (2016-2021)
9.2.2 Latin America Prescription Pain Relievers Market Size by Type (2022-2027)
9.2.3 Latin America Prescription Pain Relievers Market Size by Type (2016-2027)
9.3 Latin America Prescription Pain Relievers Market Size by Application
9.3.1 Latin America Prescription Pain Relievers Market Size by Application (2016-2021)
9.3.2 Latin America Prescription Pain Relievers Market Size by Application (2022-2027)
9.3.3 Latin America Prescription Pain Relievers Market Size by Application (2016-2027)
9.4 Latin America Prescription Pain Relievers Market Size by Country
9.4.1 Latin America Prescription Pain Relievers Market Size by Country (2016-2021)
9.4.2 Latin America Prescription Pain Relievers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prescription Pain Relievers Market Size (2016-2027)
10.2 Middle East & Africa Prescription Pain Relievers Market Size by Type
10.2.1 Middle East & Africa Prescription Pain Relievers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prescription Pain Relievers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prescription Pain Relievers Market Size by Type (2016-2027)
10.3 Middle East & Africa Prescription Pain Relievers Market Size by Application
10.3.1 Middle East & Africa Prescription Pain Relievers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prescription Pain Relievers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prescription Pain Relievers Market Size by Application (2016-2027)
10.4 Middle East & Africa Prescription Pain Relievers Market Size by Country
10.4.1 Middle East & Africa Prescription Pain Relievers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prescription Pain Relievers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prescription Pain Relievers Introduction
11.1.4 Pfizer Revenue in Prescription Pain Relievers Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Prescription Pain Relievers Introduction
11.2.4 GSK Revenue in Prescription Pain Relievers Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Details
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Prescription Pain Relievers Introduction
11.3.4 Grunenthal Revenue in Prescription Pain Relievers Business (2016-2021)
11.3.5 Grunenthal Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Prescription Pain Relievers Introduction
11.4.4 Bayer Revenue in Prescription Pain Relievers Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Prescription Pain Relievers Introduction
11.5.4 Sanofi Revenue in Prescription Pain Relievers Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Prescription Pain Relievers Introduction
11.6.4 Eli Lilly Revenue in Prescription Pain Relievers Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Prescription Pain Relievers Introduction
11.7.4 AstraZeneca Revenue in Prescription Pain Relievers Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo Prescription Pain Relievers Introduction
11.8.4 Endo Revenue in Prescription Pain Relievers Business (2016-2021)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Prescription Pain Relievers Introduction
11.9.4 Merck Revenue in Prescription Pain Relievers Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Depomed
11.10.1 Depomed Company Details
11.10.2 Depomed Business Overview
11.10.3 Depomed Prescription Pain Relievers Introduction
11.10.4 Depomed Revenue in Prescription Pain Relievers Business (2016-2021)
11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Details
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao Prescription Pain Relievers Introduction
11.11.4 Yunnan Baiyao Revenue in Prescription Pain Relievers Business (2016-2021)
11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Prescription Pain Relievers Introduction
11.12.4 Teva Revenue in Prescription Pain Relievers Business (2016-2021)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Details
11.13.2 J&J Business Overview
11.13.3 J&J Prescription Pain Relievers Introduction
11.13.4 J&J Revenue in Prescription Pain Relievers Business (2016-2021)
11.13.5 J&J Recent Development
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Prescription Pain Relievers Introduction
11.14.4 Allergan Revenue in Prescription Pain Relievers Business (2016-2021)
11.14.5 Allergan Recent Development
11.15 Purdue
11.15.1 Purdue Company Details
11.15.2 Purdue Business Overview
11.15.3 Purdue Prescription Pain Relievers Introduction
11.15.4 Purdue Revenue in Prescription Pain Relievers Business (2016-2021)
11.15.5 Purdue Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details